Varenicline attenuates some of the subjective and physiological effects of intravenous nicotine in humans

Psychopharmacology

Volumn 207, Issue 1, 2009, Pages 153-162

  Sofuoglu, Mehmet ^a   Herman, Aryeh I ^a   Mooney, Marc ^b   Waters, Andrew J ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Intravenous nicotine; Nicotine abstinence; Nicotine dependence; Varenicline

Indexed keywords

NICOTINE; VARENICLINE;

ABSENCE OF SIDE EFFECTS; ADD ON THERAPY; ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; DRUG EFFECT; DRUG MECHANISM; FEMALE; HEART RATE; HUMAN; MALE; MOOD; PHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SMOKING; STIMULATION; SYSTOLIC BLOOD PRESSURE;

ADULT; AFFECT; BENZAZEPINES; BLOOD PRESSURE; COGNITION DISORDERS; COTININE; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HEART RATE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; NICOTINE; NICOTINIC AGONISTS; QUINOXALINES; SEVERITY OF ILLNESS INDEX; SMOKING CESSATION; TOBACCO USE DISORDER; TREATMENT OUTCOME;

EID: 70350303874     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-009-1643-z     Document Type: Article

References (47)

1. K Aberger VC Chitravanshi HN Sapru 2001 Cardiovascular responses to microinjections of nicotine into the caudal ventrolateral medulla of the rat Brain Res 892 138 146 10.1016/S0006-8993(00)03250-9 1:CAS:528: DC%2BD3MXhtFSlsb0%3D 11172759 (Pubitemid 32126577)
2. M al'Absi T Amunrud LE Wittmers 2002 Psychophysiological effects of nicotine abstinence and behavioral challenges in habitual smokers Pharmacol Biochem Behav 72 707 716 10.1016/S0091-3057(02)00739-6 12175468 (Pubitemid 34450869)
3. NL Benowitz J Hukkanen P Jacob 3rd 2009 Nicotine chemistry, metabolism, kinetics and biomarkers Handb Exp Pharmacol 192 29 60 10.1007/978-3-540-69248-5- 2 19184645
4. NL Benowitz PI Jacob K Ahijevich MJ Jarvis S Hall J LeHouzec E Lichenstein JE Henningfield J Tsoh RD Hurt W Velicer 2002 Biochemical verification of tobacco use and cessation. Report from the SRNT Subcommittee on Biochemical Verification Nicotine & Tobacco Res 4 149 159 10.1080/14622200210123581 (Pubitemid 34679841)
5. TH Brandon ST Tiffany KM Obremski TB Baker 1990 Postcessation cigarette use: the process of relapse Addict Behav 15 105 114 10.1016/0306-4603(90)90013-N 1:STN:280:DyaK3c3mtFGnsA%3D%3D 2343783 (Pubitemid 20155202)
6. AR Buchhalter MC Acosta SE Evans AB Breland T Eissenberg 2005 Tobacco abstinence symptom suppression: the role played by the smoking-related stimuli that are delivered by denicotinized cigarettes Addiction 100 550 559 10.1111/j.1360-0443.2005.01030.x 15784070 (Pubitemid 40529848)
7. J Cane D Sharma I Albery 2009 The addiction Stroop task: examining the fast and slow effects of smoking and marijuana-related cues J Psychopharmacol 23 510 519 10.1177/0269881108091253 1:STN:280:DC%2BD1MvhvFahsw%3D%3D 18562413
8. JW Coe PR Brooks MG Vetelino MC Wirtz EP Arnold J Huang SB Sands TI Davis LA Lebel CB Fox A Shrikhande JH Heym E Schaeffer H Rollema Y Lu RS Mansbach LK Chambers CC Rovetti DW Schulz FD Tingley 3rd BT O'Neill 2005 Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation J Med Chem 48 3474 3477 10.1021/jm050069n 1:CAS:528:DC%2BD2MXjsFyjtb4%3D 15887955 (Pubitemid 40664098)
9. S Dhar F Nagy JM McIntosh HN Sapru 2000 Receptor subtypes mediating depressor responses to microinjections of nicotine into medial NTS of the rat Am J Physiol Regul Integr Comp Physiol 279 R132 R140 1:CAS:528: DC%2BD3cXltlyqs7c%3D 10896874
10. MV Djordjevic SD Stellman E Zang 2000 Doses of nicotine and lung carcinogens delivered to cigarette smokers J Natl Cancer Inst 92 106 111 10.1093/jnci/92.2.106 1:CAS:528:DC%2BD3cXpt1WqsA%3D%3D 10639511
11. JF Etter RJ Lukas NL Benowitz R West CM Dresler 2008 Cytisine for smoking cessation: a research agenda Drug Alcohol Depend 92 3 8 10.1016/j.drugalcdep. 2007.06.017 1:CAS:528:DC%2BD2sXhsVWjsr%2FP 17825502 (Pubitemid 350213242)
12. DE Evans DJ Drobes 2009 Nicotine self-medication of cognitive-attentional processing Addict Biol 14 32 42 10.1111/j.1369-1600.2008.00130.x 1:CAS:528:DC%2BD1MXhslykt70%3D 18855804
13. HM Faessel BJ Smith MA Gibbs JS Gobey DJ Clark AH Burstein 2006 Single-dose pharmacokinetics of varenicline, a selective nicotinic receptor partial agonist, in healthy smokers and nonsmokers J Clin Pharmacol 46 991 998 10.1177/0091270006290669 1:CAS:528:DC%2BD28XpvFOms7Y%3D 16920893 (Pubitemid 44215063)
14. CD Fowler MA Arends PJ Kenny 2008 Subtypes of nicotinic acetylcholine receptors in nicotine reward, dependence, and withdrawal: evidence from genetically modified mice Behav Pharmacol 19 461 484 10.1097/FBP. 0b013e32830c360e 1:CAS:528:DC%2BD1cXps1Wiuro%3D 18690103
15. JT Hays JO Ebbert 2008 Varenicline for tobacco dependence N Engl J Med 359 2018 2024 10.1056/NEJMct0800146 1:CAS:528:DC%2BD1cXhtleisrvO 18987369
16. TF Heatherton LT Kozlowski RC Frecker KO Fagerstrom 1991 The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire Br J Addictions 86 1119 1127 10.1111/j.1360-0443.1991.tb01879.x 1:STN:280:DyaK38%2Fjtlejtg%3D%3D
17. JR Hughes D Hatsukami 1986 Signs and symptoms of tobacco withdrawal Arch Gen Psychiatry 43 289 294 1:STN:280:DyaL287lvVWgsA%3D%3D 3954551
18. JR Hughes DK Hatsukami 1997 Effects of three doses of transdermal nicotine on post-cessation eating, hunger and weight J Subst Abuse 9 151 159 10.1016/S0899-3289(97)90013-4 1:STN:280:DyaK1c7ls1Smsg%3D%3D 9494946 (Pubitemid 29381592)
19. S Ji T Tosaka BH Whitfield AN Katchman A Kandil BC Knollmann SN Ebert 2002 Differential rate responses to nicotine in rat heart: evidence for two classes of nicotinic receptors J Pharmacol Exp Ther 301 893 899 10.1124/jpet.301.3.893 1:CAS:528:DC%2BD38XktlGjs7w%3D 12023516 (Pubitemid 34595077)
20. SL Kenford MC Fiore DE Jorenby SS Smith D Wetter TB Baker 1994 Predicting smoking cessation. Who will quit with and without the nicotine patch JAMA 271 589 594 10.1001/jama.271.8.589 1:STN:280:DyaK2c7jtlerug%3D%3D 8301790 (Pubitemid 24061691)
21. SL Kenford SS Smith DW Wetter DE Jorenby MC Fiore TB Baker 2002 Predicting relapse back to smoking: contrasting affective and physical models of dependence J Consult Clin Psychol 70 216 227 10.1037/0022-006X.70.1.216 11860048
22. C Lerman D Roth V Kaufmann J Audrain L Hawk A Liu R Niaura L Epstein 2002 Mediating mechanisms for the impact of bupropion in smoking cessation treatment Drug Alcohol Depend 67 219 223 10.1016/S0376-8716(02)00067-4 1:CAS:528:DC%2BD38XkvFyrtrY%3D 12095672 (Pubitemid 34722410)
23. JH Mendelson MB Sholar N Goletiani AJ Siegel NK Mello 2005 Effects of low- and high-nicotine cigarette smoking on mood states and the HPA axis in men Neuropsychopharmacology 30 1751 1763 10.1038/sj.npp.1300753 1:CAS:528: DC%2BD2MXotFegu7w%3D 15870834 (Pubitemid 43086032)
24. KB Mihalak FI Carroll CW Luetje 2006 Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors Mol Pharmacol 70 801 805 10.1124/mol.106.025130 1:CAS:528:DC%2BD28Xps1Sms7g%3D 16766716 (Pubitemid 44268437)
25. PA Newhouse T Sunderland PK Narang AM Mellow JB Fertig BA Lawlor DL Murphy 1990 Neuroendocrine, physiologic, and behavioral responses following intravenous nicotine in nonsmoking healthy volunteers and in patients with Alzheimer's disease Psychoneuroendocrinology 15 471 484 10.1016/0306-4530(90) 90070-P 1:CAS:528:DyaK3MXkvVGhsL8%3D 1966302
26. C Oncken D Gonzales M Nides S Rennard E Watsky CB Billing R Anziano K Reeves 2006 Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation Arch Intern Med 166 1571 1577 10.1001/archinte.166.15.1571 1:CAS:528:DC%2BD28XpsFGntr0%3D 16908789 (Pubitemid 44232364)
27. F Patterson C Jepson AA Strasser J Loughead KA Perkins RC Gur JM Frey S Siegel C Lerman 2009 Varenicline improves mood and cognition during smoking abstinence Biol Psychiatry 65 144 149 10.1016/j.biopsych.2008.08.028 1:CAS:528:DC%2BD1cXhsFChtbvN 18842256
28. PDR (2009) Physicians' Desk Reference:PDR. Medical Economics Data, Medical Economics Data
29. KA Perkins A DiMarco JE Grobe A Scierka RL Stiller 1994 Nicotine discrimination in male and female smokers Psychopharmacology (Berl) 116 407 413 10.1007/BF02247470 1:CAS:528:DyaK2MXivVGntLo%3D (Pubitemid 24374239)
30. MR Picciotto WA Corrigall 2002 Neuronal systems underlying behaviors related to nicotine addiction: neural circuits and molecular genetics J Neurosci 22 3338 3341 1:CAS:528:DC%2BD38Xjs1Shu7w%3D 11978809
31. WB Pickworth RV Fant 1998 Endocrine effects of nicotine administration, tobacco and other drug withdrawal in humans Psychoneuroendocrinology 23 131 141 10.1016/S0306-4530(97)00075-9 1:CAS:528:DyaK1cXjslWiurY%3D 9621394 (Pubitemid 28248467)
32. LS Radloff 1977 The CES-D Scale: a self-report depression scale for research in the general population Appl Psychol Meas 1 385 401 10.1177/014662167700100306
33. IH Robertson T Manly J Andrade BT Baddeley J Yiend 1997 'Oops!': performance correlates of everyday attentional failures in traumatic brain injured and normal subjects Neuropsychologia 35 747 758 10.1016/S0028-3932(97) 00015-8 1:STN:280:DyaK2szkvVCksA%3D%3D 9204482 (Pubitemid 27263222)
34. H Rollema JW Coe LK Chambers RS Hurst SM Stahl KE Williams RC Hogg D Bertrand 2007 Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation Trends Pharmacol Sci 28 316 325 10.1016/j.tips.2007.05.003 1:CAS:528:DC%2BD2sXnsFKnsr0%3D 17573127 (Pubitemid 47016686)
35. SAS Institute Inc (2007) The SAS System for Windows. SAS Institute, Cary
36. M Sofuoglu M Mouratidis S Yoo K Culligan T Kosten 2005 Effects of tiagabine in combination with intravenous nicotine in overnight abstinent smokers Psychopharmacology (Berl) 181 504 510 10.1007/s00213-005-0010-y 1:CAS:528:DC%2BD2MXhtFemtb3P (Pubitemid 41480899)
37. M Sofuoglu J Poling M Mouratidis T Kosten 2006 Effects of topiramate in combination with intravenous nicotine in overnight abstinent smokers Psychopharmacology (Berl) 184 645 651 10.1007/s00213-005-0296-9 1:CAS:528:DC%2BD28XhsFClt74%3D (Pubitemid 43255881)
38. M Sofuoglu AJ Waters M Mooney 2008 Modafinil and nicotine interactions in abstinent smokers Hum Psychopharmacol 23 21 30 10.1002/hup.878 1:CAS:528:DC%2BD1cXitFKitbk%3D 17868195 (Pubitemid 351166065)
39. M Sofuoglu AJ Waters M Mooney SS O'Malley 2009 Minocycline reduced craving for cigarettes but did not affect smoking or intravenous nicotine responses in humans Pharmacol Biochem Behav 92 135 140 10.1016/j.pbb.2008.11.004 1:CAS:528:DC%2BD1MXhtlOmt7o%3D 19041336
40. M Sofuoglu S Yoo KP Hill M Mooney 2008 Self-administration of intravenous nicotine in male and female cigarette smokers Neuropsychopharmacology 33 715 720 10.1038/sj.npp.1301460 1:CAS:528:DC%2BD1cXhvVyktr8%3D 17534380 (Pubitemid 351252695)
41. BK Son JH Markovitz S Winders D Smith 1997 Smoking, nicotine dependence, and depressive symptoms in the CARDIA Study. Effects of educational status Am J Epidemiol 145 110 116 1:STN:280:DyaK2s7lvV2ltA%3D%3D 9006307
42. WW Stoops AR Vansickel PE Glaser CR Rush 2008 The influence of acute varenicline administration on smoking and eating behavior in humans Pharmacol Biochem Behav 91 165 169 10.1016/j.pbb.2008.07.001 1:CAS:528: DC%2BD1cXhtVylu7%2FL 18675291
43. AJ Waters MA Sayette I Franken J Schwartz JA Paty 2005 Generalizability of carry-over effects in the emotional Stroop task Behavior Research and Therapy 43 715 732 10.1016/j.brat.2004.06.003 (Pubitemid 40693697)
44. AJ Waters MA Sayette JM Wertz 2003 Carry-over effects can modulate emotional Stroop effects Cogn Emot 17 501 509 10.1080/02699930143000716 (Pubitemid 36519230)
45. D Watson LA Clark A Tellegen 1988 Development and validation of brief measures of positive and negative affect: the PANAS scales J Pers Soc Psychol 54 1063 1070 10.1037/0022-3514.54.6.1063 1:STN:280:DyaL1c3os1ersA%3D%3D 3397865
46. MM Weissman D Sholomskas M Pottenger BA Prusoff BZ Locke 1977 Assessing depressive symptoms in five psychiatric populations: a validation study Am J Epidemiol 106 203 214 1:STN:280:DyaE2s3msVSqsQ%3D%3D 900119
47. R West CL Baker JC Cappelleri AG Bushmakin 2008 Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt Psychopharmacology (Berl) 197 371 377 10.1007/s00213-007-1041-3 1:CAS:528:DC%2BD1cXjsFOmsr8%3D